Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

EBS holding history

Emergent BioSolutions Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EBS overviewAll 13F holders of EBSFull Q2 2026 holdings

Shares (Q2 2026)
1,737
Value
$14.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EBS by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,737$14.6K<0.1%−239−12.1%ReducedHolders
Q1 20261,976$16.4K<0.1%−216−9.9%ReducedHolders
Q4 20252,192$27.1K<0.1%−155−6.6%ReducedHolders
Q3 20252,347$20.7K<0.1%−1,447−38.1%ReducedHolders
Q2 20253,794$24.2K<0.1%+3,074+426.9%AddedHolders
Q1 2025720$3.50K<0.1%+455+171.7%AddedHolders
Q4 2024265$2.53K<0.1%00.0%UnchangedHolders
Q3 2024265$2.21K<0.1%00.0%UnchangedHolders
Q2 2024265$1.81K<0.1%00.0%UnchangedHolders
Q1 2024265$670<0.1%−351−57.0%ReducedHolders
Q4 2023616$1.48K<0.1%−62−9.1%ReducedHolders
Q3 2023678$2.31K<0.1%−174−20.4%ReducedHolders
Q2 2023852$6.26K<0.1%−1,306−60.5%ReducedHolders
Q1 20232,158$22.4K<0.1%−1,720−44.4%ReducedHolders
Q4 20223,878$45.8K<0.1%−925−19.3%ReducedHolders
Q3 20224,803$101.0K<0.1%+1,213+33.8%AddedHolders
Q2 20223,590$112.0K<0.1%−1,061−22.8%ReducedHolders
Q1 20224,651$191.0K<0.1%−1,575−25.3%ReducedHolders
Q4 20216,226$271.0K<0.1%+1,495+31.6%AddedHolders
Q3 20214,731$237.0K<0.1%+81+1.7%AddedHolders
Q2 20214,650$293.0K<0.1%−3,608−43.7%ReducedHolders
Q1 20218,258$767.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.